                               SEQUENCE LISTING

<110> DICERNA PHARMACEUTICALS, INC.

<120> COMBINATION THERAPY WITH C-MYC NUCLEIC ACID INHIBITORS AND 
      SELECTIVE CDK7 INHIBITORS

<130> 0243.0004-PCT

<140>
<141>

<150> 62/390,059
<151> 2016-03-16

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 26
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
agcuuuuuug cccugcguga ccagac                                            26


<210> 2
<211> 38
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<220>
<223> Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide

<400> 2
uagcuaucgt gucuggucac gcagggcaaa aaagcucc                               38


<210> 3
<211> 25
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
agcuuuuuug cccugcguga ccaga                                             25


<210> 4
<211> 27
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
ucuggucacg cagggcaaaa aagcucc                                           27


